Know GvHD was pleased to speak to Hildegard Greinix, Medical University of Vienna, Austria. We asked, How do physicians decide which treatment to use in patients with graft-versus-host disease (GvHD)?

Greinix explains that GvHD can affect people in different ways, depending on which organs are involved – such as the skin, eyes, liver, gut, or lungs – and how severe the symptoms are. She describes various treatment options for different types of GvHD, with a focus on treatments for steroid-refractory chronic GvHD, including recent findings from a clinical trial of extracorporeal photopheresis plus ruxolitinib.